MYGN - MYRIAD GENETICS INC
4.5
0.140 3.111%
Share volume: 1,176,544
Last Updated: 03-31-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.36
0.14
0.03%
Summary score
36%
Profitability
25%
Dept financing
32%
Liquidity
19%
Performance
52%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 31-Dec-2013 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.61%
Return on assets
1.38%
Return on sales
9.01%
Return on invested capital
2.95%
Total debt ratio
36.88%
Debt ratio change over timeo
0%
Current Ratio
2.12%
Quick Ratio
1.83%
Cash Position Ratio
0.64%
Short-term ratios 31-Dec-2016 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.76%
Return on assets
1.67%
Return on sales
10.8%
Return on invested capital
4.3%
Total debt ratio
34.15%
Debt ratio change over timeo
0%
Current Ratio
1.86%
Quick Ratio
1.62%
Cash Position Ratio
0.55%
Last quarter ratios 31-Dec-2017
The data are presented for the financials results of the last quarter.
Return on equity
3.51%
Return on assets
1.42%
Return on sales
8.97%
Return on invested capital
4.32%
Total debt ratio
25.58%
Debt ratio change over time
0%
Current Ratio
2.05%
Quick Ratio
1.81%
Cash Position Ratio
0.56%
Performance ratios (change over 4 years) 31-Dec-2013 - 31-Dec-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MYGN | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 2.61% | -161.59% | 63.05% | -0.85% |
| Return on assets | 1.38% | 6.18% | 4.66% | 1.09% |
| Return on sales | 9.01% | 20.59% | 15.86% | 5.81% |
| Return on invested capital | 2.95% | -37.01% | 14.42% | -0.73% |
| Profitability | 23% | 50% | 88% | 11% |
| Total debt ratio | 36.88% | 102.87% | 130.65% | 52.36% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 20% | 25% | 10% |
| Current Ratio | 1.86% | 0.92% | 2.94% | 6.11% |
| Quick Ratio | 1.62% | 0.75% | 2.43% | 5.46% |
| Cash Position Ratio | 0.55% | 0.17% | 1.37% | 4.27% |
| Liquididy | 19% | 8% | 28% | 75% |
| Short-term ratios | MYGN | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 3.76% | -101.94% | 96.6% | -0.96% |
| Return on assets | 1.67% | 6.27% | 4.61% | 1.12% |
| Return on sales | 10.8% | 20.94% | 15.54% | 4.79% |
| Return on invested capital | 4.3% | -26.98% | 19.42% | -0.67% |
| Profitability | 26% | 50% | 87% | 10% |
| Total debt ratio | 34.15% | 104.01% | 123.68% | 53.85% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 21% | 25% | 11% |
| Current Ratio | 1.86% | 0.92% | 2.94% | 6.11% |
| Quick Ratio | 1.62% | 0.75% | 2.43% | 5.46% |
| Cash Position Ratio | 0.55% | 0.17% | 1.37% | 4.27% |
| Liquididy | 18% | 8% | 31% | 75% |